MINNEAPOLIS, June 6, 2011 /PRNewswire/ — Uroplasty, Inc.
(NASDAQ:
UPI), a medical device company that develops, manufactures and
markets innovative proprietary products to treat voiding
dysfunctions, announced today that its President and CEO David
Kaysen will ring the NASDAQ Stock Market Closing Bell on Tuesday,
June 7, 2011. The ceremony, held at the NASDAQ MarketSite at
Times Square in New York City, will be broadcast live beginning at
3:45 p.m. ET via the NASDAQ webcam. The live ceremony, including
Mr. Kaysen’s remarks, can be viewed online at
http://www.nasdaq.com/about/marketsitetowervideo.asx. Archived
event photos and video will also be available online, at
http://www.nasdaq.com/marketsite/marketsite_events.stm.
About Uroplasty, Inc.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with
wholly-owned subsidiaries in The Netherlands and the United
Kingdom, is a medical device company that develops, manufactures
and markets innovative proprietary products for the treatment of
voiding dysfunctions. Our focus is the continued commercialization
of our Urgent® PC Neuromodulation System, the only FDA-cleared
system that delivers posterior tibial nerve stimulation (PTNS) for
the office-based treatment of overactive bladder and associated
symptoms of urgency, frequency and urge incontinence. We also offer
Macroplastique® Implants, an injectable urethral bulking agent
for the treatment of adult female stress urinary incontinence
primarily due to
‘/>”/>
SOURCE